These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31383252)

  • 1. LRRK2 and membrane trafficking: nexus of Parkinson's disease.
    Hur EM; Jang EH; Jeong GR; Lee BD
    BMB Rep; 2019 Sep; 52(9):533-539. PubMed ID: 31383252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's Disease-Associated LRRK2 Hyperactive Kinase Mutant Disrupts Synaptic Vesicle Trafficking in Ventral Midbrain Neurons.
    Pan PY; Li X; Wang J; Powell J; Wang Q; Zhang Y; Chen Z; Wicinski B; Hof P; Ryan TA; Yue Z
    J Neurosci; 2017 Nov; 37(47):11366-11376. PubMed ID: 29054882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LRRK2 N-terminal domain influences vesicle trafficking: impact of the E193K variant.
    Marku A; Carrion MDP; Pischedda F; Marte A; Casiraghi Z; Marciani P; von Zweydorf F; Gloeckner CJ; Onofri F; Perego C; Piccoli G
    Sci Rep; 2020 Mar; 10(1):3799. PubMed ID: 32123243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 at the pre-synaptic site: A 16-years perspective.
    Pischedda F; Piccoli G
    J Neurochem; 2021 Apr; 157(2):297-311. PubMed ID: 33206398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LRRK2 and the Endolysosomal System in Parkinson's Disease.
    Erb ML; Moore DJ
    J Parkinsons Dis; 2020; 10(4):1271-1291. PubMed ID: 33044192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine-rich repeat kinase 2 and Parkinson's disease.
    Kang UB; Marto JA
    Proteomics; 2017 Jan; 17(1-2):. PubMed ID: 27723254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of LRRK2 in the regulation of dopamine receptor trafficking.
    Rassu M; Del Giudice MG; Sanna S; Taymans JM; Morari M; Brugnoli A; Frassineti M; Masala A; Esposito S; Galioto M; Valle C; Carri MT; Biosa A; Greggio E; Crosio C; Iaccarino C
    PLoS One; 2017; 12(6):e0179082. PubMed ID: 28582422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine-Rich Repeat Kinase 2 in Parkinson's Disease: Updated from Pathogenesis to Potential Therapeutic Target.
    Chen J; Chen Y; Pu J
    Eur Neurol; 2018; 79(5-6):256-265. PubMed ID: 29705795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vps35 in cooperation with LRRK2 regulates synaptic vesicle endocytosis through the endosomal pathway in Drosophila.
    Inoshita T; Arano T; Hosaka Y; Meng H; Umezaki Y; Kosugi S; Morimoto T; Koike M; Chang HY; Imai Y; Hattori N
    Hum Mol Genet; 2017 Aug; 26(15):2933-2948. PubMed ID: 28482024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential screening nominates the Parkinson's disease associated kinase LRRK2 as a regulator of Clathrin-mediated endocytosis.
    Heaton GR; Landeck N; Mamais A; Nalls MA; Nixon-Abell J; Kumaran R; Beilina A; Pellegrini L; Li Y; ; Harvey K; Cookson MR
    Neurobiol Dis; 2020 Jul; 141():104948. PubMed ID: 32434048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 and Rab GTPases.
    Pfeffer SR
    Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Parkinson's Disease Protein LRRK2 Interacts with the GARP Complex to Promote Retrograde Transport to the trans-Golgi Network.
    Beilina A; Bonet-Ponce L; Kumaran R; Kordich JJ; Ishida M; Mamais A; Kaganovich A; Saez-Atienzar S; Gershlick DC; Roosen DA; Pellegrini L; Malkov V; Fell MJ; Harvey K; Bonifacino JS; Moore DJ; Cookson MR
    Cell Rep; 2020 May; 31(5):107614. PubMed ID: 32375042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 and vesicle trafficking.
    Sanna G; Del Giudice MG; Crosio C; Iaccarino C
    Biochem Soc Trans; 2012 Oct; 40(5):1117-22. PubMed ID: 22988875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 at the interface of autophagosomes, endosomes and lysosomes.
    Roosen DA; Cookson MR
    Mol Neurodegener; 2016 Dec; 11(1):73. PubMed ID: 27927216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
    Rassu M; Biosa A; Galioto M; Fais M; Sini P; Greggio E; Piccoli G; Crosio C; Iaccarino C
    J Cell Mol Med; 2019 Dec; 23(12):8505-8510. PubMed ID: 31560168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.
    Gómez-Suaga P; Rivero-Ríos P; Fdez E; Blanca Ramírez M; Ferrer I; Aiastui A; López De Munain A; Hilfiker S
    Hum Mol Genet; 2014 Dec; 23(25):6779-96. PubMed ID: 25080504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caught in the act: LRRK2 in exosomes.
    Wang S; West AB
    Biochem Soc Trans; 2019 Apr; 47(2):663-670. PubMed ID: 30837321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cell Biology of LRRK2 in Parkinson's Disease.
    Usmani A; Shavarebi F; Hiniker A
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33526455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 links genetic and sporadic Parkinson's disease.
    Kluss JH; Mamais A; Cookson MR
    Biochem Soc Trans; 2019 Apr; 47(2):651-661. PubMed ID: 30837320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.